196 results
Page 9 of 10
8-K
EX-99.1
baj6mn9ija67u
20 Jul 16
ContraVir Pharmaceuticals to Present at 41st Annual International Herpesvirus Workshop
12:00am
8-K
EX-99.1
46ug0co xpj
18 Jul 16
Appoints Four Renowned Hepatitis B Experts; Carol L. Brosgart, M.D., to Serve as Chair of the Board
12:00am
424B5
d9gan
7 Oct 15
Prospectus supplement for primary offering
12:00am
8-K
EX-99.2
2u4h 347w
7 Oct 15
Contravir Pharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock and Warrants to Purchase Common Stock
12:00am
8-K
977uiczj
7 Oct 15
Contravir Pharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock and Warrants to Purchase Common Stock
12:00am
8-K
EX-99.1
v1m 8adn2
7 Oct 15
Contravir Pharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock and Warrants to Purchase Common Stock
12:00am
8-K
EX-1.1
iwqxyvk8 vtwfg1le
7 Oct 15
Contravir Pharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock and Warrants to Purchase Common Stock
12:00am
8-K
EX-99.1
o7vujtm
25 Feb 15
ContraVir Pharmaceuticals Announces Uplisting to The NASDAQ Capital Market
12:00am
8-K
EX-99.1
lxesbry mj8
20 Feb 15
ContraVir Pharmaceuticals Provides Clinical Update on FV-100
12:00am
8-K
EX-99.1
w7fhevjr 86o
4 Feb 15
ContraVir Pharmaceuticals’ HBV Compound CMX157 Receives Extended Patent Life
12:00am
8-K
EX-99.1
4egqqolju nrs
20 Jan 15
ContraVir Pharmaceuticals Adds Carol L. Brosgart, M.D., to Scientific Advisory Board
12:00am
8-K
EX-99.1
er5h19t 75lu2xmt1
15 Jan 15
ContraVir Pharmaceuticals Appoints John Sullivan-Bolyai, M.D., MPH, as Chief Medical Officer
12:00am
8-K
EX-99.1
9ei4qtgnx
8 Jan 15
ContraVir Pharmaceuticals adds Renu Gupta, M.D., to Scientific Advisory Board
12:00am
8-K
EX-99.1
w7rf8qaev60dkm mu5ys
7 Jan 15
ContraVir Pharmaceuticals Granted FDA Meeting to Discuss Proposal for Phase 3 Trial of FV-100
12:00am
8-K
EX-99.1
6n0w6xi
18 Dec 14
Chimerix and ContraVir Pharmaceuticals Establish Strategic Collaboration for Antiviral Drug Candidate CMX157
12:00am
8-K
EX-99.1
348qvn0r c8gxo
16 Dec 14
ContraVir Pharmaceuticals Appoints Nathaniel Katz, M.D., Chairman of New Scientific Advisory Board Chair
12:00am